In summary, among a sample of PCPs in WA State who were a mix of prescribers and non-prescribers of buprenorphine, we found that although our findings did not reach statistical significance, those who prescribe buprenorphine were more likely to screen and treat patients for HCV.
← all excerpts
Hepatitis C care delivery practices among buprenorphine prescribers and non-prescribers: results from a survey of Washington state primary care providers.
1
—
—